KH

Kristoffer Hellstrand

MP Maxim Pharmaceuticals: 16 patents #2 of 22Top 10%
Overall (All Time): #302,036 of 4,157,543Top 8%
16
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
6893633 Methods and compositions for promoting the maturation of monocytes Svante Hermodsson, Kurt R. Gehlsen 2005-05-17
6821510 Methods and compositions for promoting the maturation of monocytes Svante Hermodsson, Kurt R. Gehlsen 2004-11-23
6790440 Methods and compositions for promoting the maturation of monocytes Svante Hermodsson, Kurt R. Gehlsen 2004-09-14
6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Svante Hermodsson, Kurt R. Gehlsen 2004-05-04
6613788 Elevation of circulating blood histamine levels Svante Hermodsson, Kurt R. Gehlsen 2003-09-02
6498181 Synergistic tumorcidal response induced by histamine Kurt R. Gehlsen, Svante Hermodsson 2002-12-24
6462067 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Svante Hermodsson, Kurt R. Gehlsen 2002-10-08
6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Svante Hermodsson, Kurt R. Gehlsen 2002-06-18
6305380 Method for treatment of cancer and infectious disease Svante Hermodsson 2001-10-23
6242473 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Svante Hermodsson, Kurt R. Gehlsen 2001-06-05
6221893 Administration of histamine for therapeutic purposes Svante Hermodsson, Kurt R. Gehlsen 2001-04-24
6155266 Method for treatment of cancer and infectious disease Svante Hermodsson 2000-12-05
6071942 Elevation of circulating blood histamine levels Svante Hermodsson, Kurt R. Gehlsen 2000-06-06
6003516 Method for treatment of cancer and infectious disease Svante Hermodsson 1999-12-21
5961969 Stable circulating histamine levels Svante Hermodsson 1999-10-05
5728378 Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity Svante Hermodsson 1998-03-17